BMJ Case Reports · 2018 · 10 citations · 3 references
PharmacyPediatricsPharmacotherapyNeonatologyPediatric Clinical PharmacologyPediatric TherapeuticsLactation PharmacotherapyNeonatal Drug TherapyNeonatal PharmacologyNeonatal PharmacotherapyChylothorax InterventionMedium-chain Triglyceride DietMedium-chain Triglyceride EmulsionsOctreotide TherapyProduct Safety Profile
Congenital chylothorax (CC) is a rare entity in neonatal period requiring multimodal management strategies. Despite optimum treatment, some cases remain refractory posing significant challenge to the treating physician. We here describe a 33-week preterm neonate presenting with refractory congenital chylothorax who needed treatment with combination of skimmed milk, high dose and prolonged duration octreotide for resolution. This case highlighted that octreotide has a good safety profile in newborn infants with congenital chylothorax and locally available skimmed milk fortified with medium chain triglyceride (MCT) oil is a cheap and safe alternative.
3
Vera Büttiker, Sergio Fanconi, Réne Burger · CHEST Journal · 1999 · 256 citations